Related Experiment Video
Updated: May 30, 2026

07:30
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Tract-specific white matter structural disruption in patients with bipolar disorder
Francesco Benedetti1, Martina Absinta, Maria A Rocca
1Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milano, Italy. benedetti.francesco@hsr.it
Bipolar Disorders
|August 17, 2011
Summary
Bipolar disorder (BD) patients show specific white matter (WM) abnormalities in emotional brain networks. These disruptions may explain mood and cognitive issues in BD and serve as a treatment monitoring marker.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Mood disorders like major depressive disorder (MDD) and bipolar disorder (BD) are linked to emotional and cognitive network dysfunction.
- Brain network abnormalities, beyond localized lesions, are increasingly implicated in mood disorders.
Purpose of the Study:
- To quantify structural injury in white matter (WM) connections of the emotional network using diffusion tensor (DT) tractography.
- To investigate structural differences in the limbic network between patients with MDD, BD, and healthy controls.
Main Methods:
- Acquired conventional and DT magnetic resonance imaging (MRI) brain scans from 15 MDD patients, 15 BD patients, and 21 healthy controls.
- Utilized FSL software to measure diffusivity changes in WM fiber bundles of the emotional network.
- Focused on connections between the amygdala and regions including the cingulate cortex, parahippocampal cortex, orbitofrontal cortex, dorsolateral prefrontal cortex, and insula.
Main Results:
- Bipolar disorder patients exhibited significantly decreased fractional anisotropy and increased mean, axial, and radial diffusivity in anterior limbic network WM fiber bundles compared to controls and MDD patients.
- These diffusivity changes were observed in most WM fiber bundles connecting limbic structures.
- Lithium medication was associated with normalized diffusivity in tracts connecting the amygdala and subgenual cingulate cortex.
Conclusions:
- Detected specific WM abnormalities indicating disrupted fiber bundle integrity in bipolar disorder (BD) patients.
- These findings may elucidate mood dysregulation and cognitive deficits in BD.
- WM abnormalities could serve as objective markers for monitoring treatment efficacy in BD.
Related Concept Videos
Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
